List of Tables
    Table 1. Imatinib Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Imatinib Drug Market Trends
    Table 3. Imatinib Drug Market Drivers
    Table 4. Imatinib Drug Market Challenges
    Table 5. Imatinib Drug Market Restraints
    Table 6. Global Imatinib Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Imatinib Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Imatinib Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Imatinib Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Imatinib Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Imatinib Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Imatinib Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Imatinib Drug Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Imatinib Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Imatinib Drug Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Imatinib Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2021)
    Table 18. Top Players of Imatinib Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Imatinib Drug Product Type
    Table 20. Date of International Manufacturers Enter into Imatinib Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Imatinib Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Imatinib Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Imatinib Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Imatinib Drug Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Imatinib Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Imatinib Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Imatinib Drug Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Imatinib Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Imatinib Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Imatinib Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Imatinib Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Imatinib Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Imatinib Drug Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Imatinib Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Imatinib Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Imatinib Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Imatinib Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Imatinib Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Imatinib Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Imatinib Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novartis Corporation Information
    Table 43. Novartis Description and Business Overview
    Table 44. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Novartis Imatinib Drug Product
    Table 46. Novartis Recent Development
    Table 47. Glenmark Pharmaceuticals Ltd. Corporation Information
    Table 48. Glenmark Pharmaceuticals Ltd. Description and Business Overview
    Table 49. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Glenmark Pharmaceuticals Ltd. Product
    Table 51. Glenmark Pharmaceuticals Ltd. Recent Development
    Table 52. Sun Pharmaceuticals Corporation Information
    Table 53. Sun Pharmaceuticals Description and Business Overview
    Table 54. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Sun Pharmaceuticals Product
    Table 56. Sun Pharmaceuticals Recent Development
    Table 57. Actavis Generics Corporation Information
    Table 58. Actavis Generics Description and Business Overview
    Table 59. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Actavis Generics Product
    Table 61. Actavis Generics Recent Development
    Table 62. Dr. Reddy's Laboratories Corporation Information
    Table 63. Dr. Reddy's Laboratories Description and Business Overview
    Table 64. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Dr. Reddy's Laboratories Product
    Table 66. Dr. Reddy's Laboratories Recent Development
    Table 67. Teva Pharmaceutical Industries Ltd. Corporation Information
    Table 68. Teva Pharmaceutical Industries Ltd. Description and Business Overview
    Table 69. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Teva Pharmaceutical Industries Ltd. Product
    Table 71. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 72. Sanofi S.A. Corporation Information
    Table 73. Sanofi S.A. Description and Business Overview
    Table 74. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Sanofi S.A. Product
    Table 76. Sanofi S.A. Recent Development
    Table 77. Cipla Inc. Corporation Information
    Table 78. Cipla Inc. Description and Business Overview
    Table 79. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Cipla Inc. Product
    Table 81. Cipla Inc. Recent Development
    Table 82. Apotex Inc. Corporation Information
    Table 83. Apotex Inc. Description and Business Overview
    Table 84. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Apotex Inc. Product
    Table 86. Apotex Inc. Recent Development
    Table 87. Mylan Pharms Inc. Corporation Information
    Table 88. Mylan Pharms Inc. Description and Business Overview
    Table 89. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Mylan Pharms Inc. Product
    Table 91. Mylan Pharms Inc. Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Imatinib Drug Customers List
    Table 95. Imatinib Drug Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Imatinib Drug Product Picture
    Figure 2. Global Imatinib Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Imatinib Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Imatinib Drug Sales 2017-2028 (K Units)
    Figure 5. United States Imatinib Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Imatinib Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Imatinib Drug Sales 2017-2028 (K Units)
    Figure 8. United States Imatinib Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Imatinib Drug Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Imatinib Drug Report Years Considered
    Figure 11. Product Picture of Tablets
    Figure 12. Product Picture of Capsules
    Figure 13. Global Imatinib Drug Market Share by Type in 2022 & 2028
    Figure 14. Global Imatinib Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Imatinib Drug Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Imatinib Drug Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Imatinib Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Imatinib Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Imatinib Drug Market Share by Type in 2022 & 2028
    Figure 20. United States Imatinib Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Imatinib Drug Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Imatinib Drug Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Imatinib Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Imatinib Drug Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Chronic Myelogenous Leukemia
    Figure 26. Product Picture of Gastrointestinal Stromal Tumors
    Figure 27. Product Picture of Others
    Figure 28. Global Imatinib Drug Market Share by Application in 2022 & 2028
    Figure 29. Global Imatinib Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Imatinib Drug Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Imatinib Drug Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Imatinib Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Imatinib Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Imatinib Drug Market Share by Application in 2022 & 2028
    Figure 35. United States Imatinib Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Imatinib Drug Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Imatinib Drug Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Imatinib Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Imatinib Drug Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Imatinib Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Imatinib Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Imatinib Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Imatinib Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Imatinib Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Imatinib Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Imatinib Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Imatinib Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Imatinib Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Imatinib Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Imatinib Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Imatinib Drug Value Chain
    Figure 74. Imatinib Drug Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed